First Melanoma Blood Test to Detect Skin Cancer

By , in Health News on . Tagged width: ,

Melanoma (in its early stages) can be now detected with the help of the world’s first blood test, which was invented by scientists from Australia.

The scientists stated that this test gives a more precise diagnosis, making humans inferior.

In this study took part around 209 people, and it demonstrated that the test was able to track the early stage melanoma in about 81.5% of cases.

So..what’s the next step?

Scientists from the Edith Cowan University are now ready to conduct some more clinical trials to make sure that the test is safe and, also, to authorize the results. Their hopes are high, and they believe that the test will be available in about 3 to 5 years.

How is this test beneficial for everyone

This test can save thousands of lives; we can all imagine that. Having a clear diagnosis in the early stages of melanoma it’s a big thing since the disease is kind of difficult to detect with the human eye, especially if the melanoma is small. For some people, particularly for those who live in rural areas, is hard to get a doctor. This is why this important is so important.

Around 1,500 people die from melanoma each year. Only in 2017, 14,000 cases were diagnosed. To detect cancer, doctors check the skin of the patient to see if there are any changes in the moles or spots from it before putting on a diagnosis.

This test detects ten combinations of proteins and autoantibodies which are produced by the body when it responds to cancer. They now want to improve the sensitivity of the test and to do that; they need to work on clinical trials and compare the test results to the biopsies of the suspected melanomas.

As our second lead editor, Anna C. Mackinno provides guidance on the stories Great Lakes Ledger reporters cover. She has been instrumental in making sure the content on the site is clear and accurate for our readers. If you see a particularly clever title, you can likely thank Anna. Anna received a BA and and MA from Fordham University.